Kaken Pharmaceutical Co., Ltd. (TYO:4521)
Japan · Delayed Price · Currency is JPY 3,820.00
+25.00 (0.66%)
Aug 3, 2026, 3:30 PM JST
Kaken Pharmaceutical Market Cap
Kaken Pharmaceutical has a market cap or net worth of 144.66 billion as of August 3, 2026. Its market cap has decreased by -4.11% in one year.
Market Cap
144.66B
Enterprise Value
97.80B
Revenue
76.87B
Ranking
n/a
PE Ratio
67.55
Stock Price
3,820.00
ChartMarket Cap Chart
Since March 26, 1993, Kaken Pharmaceutical's market cap has increased from 118.38B to 144.66B, an increase of 22.20%. That is a compound annual growth rate of 0.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 144.66B | -4.86% |
| Dec 30, 2025 | 152.04B | -11.05% |
| Dec 30, 2024 | 170.93B | 34.53% |
| Dec 29, 2023 | 127.05B | -12.84% |
| Dec 30, 2022 | 145.77B | -8.45% |
| Dec 30, 2021 | 159.22B | 3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sumitomo Pharma | 569.94B |
| Tsumura & Co. | 282.53B |
| Nippon Shinyaku | 230.71B |
| Towa Pharmaceutical | 192.48B |
| Sawai Group Holdings | 186.68B |
| Kissei Pharmaceutical | 169.33B |
| Mochida Pharmaceutical | 112.64B |
| Zeria Pharmaceutical | 91.20B |